Attached files

file filename
EX-12 - STATEMENTS REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES - ALTRIA GROUP, INC.exhibit12computationofrati.htm
10-Q - FORM 10-Q - ALTRIA GROUP, INC.a2017form10qq22017.htm
EX-99.1 - CERTAIN LITIGATION MATTERS - ALTRIA GROUP, INC.exhibit991q22017.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC.exhibit322q22017.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC.exhibit321q22017.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC.exhibit312q22017.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC.exhibit311q22017.htm
EX-10.1 - AGREEMENT & GENERAL RELEASE BETWEEN ALTRIA GROUP, INC. AND DENISE F. KEANE - ALTRIA GROUP, INC.exhibit101agreementgeneral.htm

Exhibit 99.2



TRIAL SCHEDULE FOR CERTAIN CASES

Below is a schedule, as of July 24, 2017, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for trial through September 30, 2017.

2017

Engle progeny                        
July
0
 
 
August
2
 
 
September
2

As of July 24, 2017, there was one Engle progeny case in trial.

Other Individual Smoking & Health
July
0
 
 
August
0
 
 
September
1

As of July 24, 2017, there were no non-Engle progeny cases in trial.